Neuronetics Achieves Positive Operating Cash Flow of $0.9M in Q4
During the fourth quarter, the company drove positive operating cash flow of $0.9M, in line with previously issued guidance. "We wrapped up 2025 with strong commercial execution during the fourth quarter across both segments of the business. We continue to see solid demand for NeuroStar systems and are proud to see our NeuroStar customers helping more patients in need. Our clinic business had another exciting quarter as we continue to optimize our operations while also driving significant revenue growth," said Keith Sullivan, president and CEO of Neuronetics. "Importantly, we translated this strong revenue performance into positive operating cash flow during the quarter and maintained the strength of our balance sheet as we move into 2026."
